The 9 lives of β-catenin

Human Pathology

Volumn 35, Issue 6, 2004, Pages 647-648

  Mittal, Khush ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; TRANSACTIVATOR PROTEIN;

ANAPLASTIC CARCINOMA; CANCER GENETICS; CELL ADHESION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLON CARCINOMA; COLON POLYP; CYTOSKELETON; DISEASE ASSOCIATION; EDITORIAL; ENDOMETRIUM CARCINOMA; ESOPHAGUS CARCINOMA; FIBROMATOSIS; GENE MUTATION; HEPATOBLASTOMA; HUMAN; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; OVARY CARCINOMA; PERITONEUM METASTASIS; PILOMATRIXOMA; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; STAINING; THYROID CARCINOMA; ANIMAL; FEMALE; GENETICS; METABOLISM; MUTATION; NEOPLASM; NOTE; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; BETA CATENIN; CYTOSKELETAL PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; MUTATION; NEOPLASMS; TRANS-ACTIVATORS;

EID: 3042728596     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.04.006     Document Type: Editorial

References (30)

1. Faleiro-Rodrigues C., Macedo-Pinto I.M., Pereira D., et al. Association of E-cadherin and β-catenin immunoexpression with clinicopathological features in primary ovarian carcinoma. Hum Pathol. 35:2004;663-669
2. Ozawa M., Baribault H., Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1989;1711-1717
3. Hirano S., Kimoto N., Shimoyama Y., et al. Identification of a neural a-catenin as a key regulator of cadherin function and multicellular organization. Cell. 70:1992;293-301
4. Nathke I., Hinck L., Swedlow J., et al. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J Cell Biol. 125:1994;1341-1352
5. Zhao X.J., Li H., Chen H., et al. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma Relationships with prognosis. World J Gastroenterol. 9:2003;225-232
6. Choi Y.S., Shim Y.M., Kim S.H., et al. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 24:2003;441-449
7. Korinek V., Barker N., Morin P.J., et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 275:1997;1784-1787
8. Romagnolo B., Berrebi D., Saadi-Keddoucci S., et al. Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res. 59:1999;3875-3879
9. Sparks A.B., Morin P.J., Vogelstein B., et al. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58:1998;1130-1134
10. Morin P.J., Sparks A.B., Korinek V., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 275:1997;1787-1790
11. Jeng Y.M., Wu M.Z., Mao T.L., et al. Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett. 152:2001;45-51
12. Chan E.F., Gat U., McNiff J.M., et al. A common human skin tumor is caused by activating mutations in beta-catenin. Nat Genet. 21:1999;410-413
13. Garcia-Rostan G., Tallini G., Herrero A., et al. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res. 59:1999;1811-1815
14. Palacios J., Gamallo C. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res. 58:1998;1344-1347
15. Fukuchi T., Sakamoto M., Tsuda H., et al. Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res. 58:1998;3526-3528
16. Huang H., Fujii H., Sankila A., et al. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol. 155:1801;1795
17. Koesters R., Ridder R., Kopp-Schneider A., et al. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res. 59:1999;3880-3882
18. Voeller H.J., Truica C.I., Gelmann E.P. Beta-catenin mutations in human prostate cancer. Cancer Res. 58:1998;2520-2523
19. Zurawel R.H., Chiappa S.A., Allen C., et al. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res. 58:1998;896-899
20. Abraham S.C., Wu T.T., Klimstra D.S., et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas Frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol. 59:2001;1619-1627
21. Abraham S.C., Wu T.T., Hruban R.H., et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma Frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol. 160:2002;953-962
22. Abraham S.C., Klimstra D.S., Wilentz R.E., et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 160:2002;1361-1369
23. Miyoshi Y., Iwao K., Nawa G., et al. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res. 10:1998;591-594
24. Zhang P., Furth E.E., Cai X., et al. The role of β-catenin, TGF-β3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids. Hum Pathol. 35:2004;370-374
25. Wong S.C., Lo E.S., Chan A.K., et al. Nuclear beta-catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong. Mol Pathol. 56:2003;347-352
26. Kolligs F.T., Bommer G., Göke B. Wnt/beta-catenin/Tcf signaling A critical pathway in gastrointestinal tumorigenesis. Digestion. 66:2002;131-144
27. Mirabelli-Primdahl L., Gryfe R., Kim H., et al. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res. 59:1999;3346-3351
28. Heasman J., Crawford A., Goldstone K., et al. Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell. 79:1994;791-803
29. Zechner D., Fujita Y., Hulsken J., et al. Beta-catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev Biol. 258:2003;406-418
30. Cadigan K.M., Nusse R. Wnt signaling a common theme in animal development. Gene Dev. 24:1997;3286-3305